BEATW Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.500.0% YoY
Profit margin0.0%HEALTHCARE
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
-164.2%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
Last earnings
Jun 30, 2021 · Estimate $0.00 · Reported $-0.26
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Heartbeam Inc. Warrant

Heartbeam Inc. Warrant (BEATW) offers a unique investment prospect linked to Heartbeam Inc., a pioneering healthcare technology firm dedicated to revolutionizing cardiac diagnostics via advanced artificial intelligence and digital health solutions. The company's innovative platform aims to increase the accuracy of myocardial infarction diagnoses, enabling timely and effective interventions that enhance patient care. As the demand for remote monitoring and telehealth services in cardiovascular health continues to rise, Heartbeam Inc. is strategically positioned to leverage this growth, making…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
NONE
Fiscal year end
December
Latest quarter
Dec 31, 2025
Shares outstanding$0
52W high$0.78
52W low$0.07

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer